StockData
CalciMedica, Inc. logo

CalciMedica, Inc. (CALC) stock

CALCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 1/30
$1.22+0.03 (+2.52%)

Close on Nov 17, 2026Market cap $41.65MP/E –Yield –

CalciMedica cash

Cash and short-term investments held at the end of each period.

CalciMedica's cash was $18.60M at Jun 30, 2026. For fiscal 2025 it was $13.00M, down 30.5% from the year before. The highest annual figure on record is $95.03M in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$13.00M-30.5%
FY2024Dec 31, 2024$18.70M+67.0%
FY2023Dec 31, 2023$11.20M+744.0%
FY2022Dec 31, 2022$1.33M-97.9%
FY2021Dec 31, 2021$63.67M-33.0%
FY2020Dec 31, 2020$95.03M+164.3%
FY2019Dec 31, 2019$35.96M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$18.60M+3.3%
Q1 FY2026Mar 31, 2026$8.20M-66.7%
Q4 FY2025Dec 31, 2025$13.00M-30.5%
Q3 FY2025Sep 30, 2025$14.10M-3.4%
Q2 FY2025Jun 30, 2025$18.00M-5.8%
Q1 FY2025Mar 31, 2025$24.60M-4.3%
Q4 FY2024Dec 31, 2024$18.70M+67.0%
Q3 FY2024Sep 30, 2024$14.60M0.0%
Q2 FY2024Jun 30, 2024$19.10M+0.1%
Q1 FY2024Mar 31, 2024$25.70M-24.9%
Q4 FY2023Dec 31, 2023$11.20M+744.0%
Q3 FY2023Sep 30, 2023$14.60M-71.2%
Q2 FY2023Jun 30, 2023$19.08M-65.5%
Q1 FY2023Mar 31, 2023$34.20M-46.3%
Q4 FY2022Dec 31, 2022$1.33M-98.2%
Q2 FY2022Jun 30, 2022$50.69M-31.1%
Q1 FY2022Mar 31, 2022$55.28M-35.5%
Q4 FY2021Dec 31, 2021$63.67M-33.0%
Q3 FY2021Sep 30, 2021$72.55M-23.6%
Q2 FY2021Jun 30, 2021$73.59M+104.7%
Q1 FY2021Mar 31, 2021$85.69M–
Q4 FY2020Dec 31, 2020$95.03M–
Q3 FY2020Sep 30, 2020$94.97M–
Q4 FY2019Dec 31, 2019$35.96M–

More CalciMedica figures

See a number that looks wrong?